Export 6 results:
Author Title [ Type(Desc)] Year
Filters: Author is Sztein, Marcelo B  [Clear All Filters]
Journal Article
S. S. El-Kamary, Pasetti, M. F., Mendelman, P. M., Frey, S. E., Bernstein, D. I., Treanor, J. J., Ferreira, J., Chen, W. H., Sublett, R., Richardson, C., Bargatze, R. F., Sztein, M. B., and Tacket, C. O., Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues., J Infect Dis, vol. 202, no. 11, pp. 1649-58, 2010.
D. I. Bernstein, Pasetti, M. F., Brady, R., Buskirk, A. D., Wahid, R., Dickey, M., Cohen, M., Baughman, H., El-Khorazaty, J., Maier, N., Sztein, M. B., Baqar, S., and A Bourgeois, L., A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization., Vaccine, vol. 37, no. 4, pp. 602-611, 2019.
M. S. Natrajan, Rouphael, N., Lai, L., Kazmin, D., Jensen, T. L., Weiss, D. S., Ibegbu, C., Sztein, M. B., Hooper, W. F., Hill, H., Anderson, E. J., Johnson, R., Sanz, P., Pulendran, B., Goll, J. B., and Mulligan, M. J., Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses., Vaccines (Basel), vol. 8, no. 1, 2019.
M. J. Mulligan, Stapleton, J. T., Keitel, W. A., Frey, S. E., Chen, W. H., Rouphael, N., Edupuganti, S., Beck, A., Winokur, P. L., Sahly, H. M. El, Patel, S. M., Atmar, R. L., Graham, I., Anderson, E., El-Kamary, S. S., Pasetti, M. F., Sztein, M. B., Hill, H., and Goll, J. B., Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial., Vaccine, vol. 35, no. 36, pp. 4730-4737, 2017.
M. D. Tapia, Sow, S. O., Lyke, K. E., Haidara, F. Cheick, Diallo, F., Doumbia, M., Traore, A., Coulibaly, F., Kodio, M., Onwuchekwa, U., Sztein, M. B., Wahid, R., Campbell, J. D., Kieny, M. - P., Moorthy, V., Imoukhuede, E. B., Rampling, T., Roman, F., De Ryck, I., Bellamy, A. R., Dally, L., Mbaya, O. Tshiani, Ploquin, A., Zhou, Y., Stanley, D. A., Bailer, R., Koup, R. A., Roederer, M., Ledgerwood, J., Hill, A. V. S., W Ballou, R., Sullivan, N., Graham, B., and Levine, M. M., Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-bli, Lancet Infect Dis, vol. 16, no. 1, pp. 31-42, 2016.
R. Salerno-Gonçalves, Chen, W. H., Mulligan, M. J., Frey, S. E., Stapleton, J. T., Keitel, W. A., Bailey, J., Sendra, E., Hill, H., Johnson, R. A., and Sztein, M. B., Vaccine-related major cutaneous reaction size correlates with cellular-mediated immune responses after tularaemia immunisation., Clin Transl Immunology, vol. 10, no. 1, p. e1239, 2021.